Back to CELG Stock Lookup

CELG Related

Jun 17, 2013 04:15 PM Form 4 CELGENE CORP /DE/ For: Jun 13 Filed by: MARIO ERNEST

Jun 17, 2013 04:14 PM Form 4 CELGENE CORP /DE/ For: Jun 13 Filed by: KAPLAN GILLA

Jun 17, 2013 04:14 PM Form 4 CELGENE CORP /DE/ For: Jun 13 Filed by: LOUGHLIN JAMES J

Jun 17, 2013 04:13 PM Form 4 CELGENE CORP /DE/ For: Jun 16 Filed by: HUGIN ROBERT J

Jun 17, 2013 04:12 PM Form 4 CELGENE CORP /DE/ For: Jun 13 Filed by: Friedman Michael A

Jun 17, 2013 04:12 PM Form 4 CELGENE CORP /DE/ For: Jun 13 Filed by: DRAKE RODMAN L

Jun 17, 2013 04:11 PM Form 4 CELGENE CORP /DE/ For: Jun 13 Filed by: BARKER RICHARD W

Jun 17, 2013 04:11 PM Form 4 CELGENE CORP /DE/ For: Jun 13 Filed by: CASEY MICHAEL D

Jun 17, 2013 01:30 AM Oral Anti-Cancer Therapy REVLIMID® (lenalidomide) Now Indicated as a Treatment for Patients with Rare Form of Blood Disease

Jun 14, 2013 04:22 PM Form 4 CELGENE CORP /DE/ For: Jun 12 Filed by: MARIO ERNEST

Jun 14, 2013 04:22 PM Form 4 CELGENE CORP /DE/ For: Jun 12 Filed by: KAPLAN GILLA

Jun 14, 2013 04:22 PM Form 4 CELGENE CORP /DE/ For: Jun 12 Filed by: LOUGHLIN JAMES J

Jun 14, 2013 04:18 PM Form 4 CELGENE CORP /DE/ For: Jun 12 Filed by: DRAKE RODMAN L

Jun 14, 2013 04:18 PM Form 4 CELGENE CORP /DE/ For: Jun 12 Filed by: Friedman Michael A

Jun 14, 2013 04:17 PM Form 4 CELGENE CORP /DE/ For: Jun 12 Filed by: COX CARRIE SMITH

Jun 14, 2013 04:16 PM Form 4 CELGENE CORP /DE/ For: Jun 12 Filed by: BARKER RICHARD W

Jun 14, 2013 04:16 PM Form 4 CELGENE CORP /DE/ For: Jun 12 Filed by: CASEY MICHAEL D

Jun 14, 2013 06:21 AM Celgene Int'l (CELG) Apremilast Hits Primary, Secondary Endpoints in BD Phase II

Jun 14, 2013 06:04 AM Oral Apremilast Achieves Statistical Significance for Primary and Secondary Endpoints in a Phase II Trial in Patients with Behçet’s Disease

Jun 13, 2013 05:08 PM Form 8-K CELGENE CORP /DE/ For: Jun 12

Jun 13, 2013 07:48 AM Argus Upgrades Celgene (CELG) to Buy

Jun 13, 2013 04:30 AM Data from Phase III Randomized Controlled Study (PALACE 3) of Apremilast in Psoriatic Arthritis Presented at EULAR

Jun 12, 2013 04:50 PM Moody's Boosts Outlook on Celgene (CELG) to Stable; Affirms Ratings

Jun 12, 2013 09:40 AM StreetInsider.com Pre-Open Movers 6/12: (CTB) (CYTK) (HMA) Higher; (CLSN) (FSLR) (IEP) Lower (more...)

Jun 12, 2013 08:01 AM Celgene (CELG) Adds $3B to Buyback Plan

Jun 12, 2013 08:00 AM Celgene Announces Additional $3.0 Billion Share Repurchase Program

Jun 12, 2013 07:35 AM Celgene (CELG) Unit Reports Meaningful Improvements Observed in PALACE 1

Jun 12, 2013 07:30 AM Signs and Symptoms of Psoriatic Arthritis Significantly Improved in Patients Receiving Long-Term Oral Apremilast Treatment in Phase III Study (PALACE-1)

Jun 7, 2013 04:07 PM Form 4 CELGENE CORP /DE/ For: Jun 05 Filed by: MARIO ERNEST

Jun 6, 2013 08:00 AM Celgene Corporation to Webcast at Upcoming Investor Conference

Jun 5, 2013 01:02 PM FDA Approves Approves Celgene (CELG) sNDA for REVLIMID

Jun 5, 2013 01:00 PM U.S. Food and Drug Administration Approves REVLIMID® (lenalidomide) for the Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma

Jun 3, 2013 03:27 PM Notable 50-Day SMA Crossers 06/03: (NOK) (FCX) (CVS) Above; (CELG) (X) (FFIV) Below

Jun 3, 2013 12:30 PM Analyses of MPACT Trial Evaluating ABRAXANE® Combination Therapy for the Treatment of Advanced Pancreatic Cancer Presented at ASCO 2013

Jun 3, 2013 09:49 AM Celgene (CELG) Provides Update on POMALYST

Jun 3, 2013 09:32 AM Updated Studies Evaluating POMALYST® (pomalidomide) In Previously Treated Multiple Myeloma Patients Presented at ASCO

Jun 3, 2013 09:24 AM Celgene (CELG) Unit to Present Statistically Significant Data from MPR on Multiple Myeloma

Jun 3, 2013 09:20 AM Study Evaluating REVLIMID® Combination Compared to Autologous Stem Cell Transplant with or without REVLIMID Maintenance in Newly-Diagnosed Multiple Myeloma Presented at ASCO

May 31, 2013 08:30 AM Celgene Announces Launch of “Innovation Impact” Awards to Recognize Excellence in Creative Patient, Caregiver or Healthcare Provider Programs

May 31, 2013 06:26 AM Celgene (CELG) Reports EMA CHMP Adopts Positive Opinion for Pomalidomide

May 31, 2013 06:22 AM Oral Anti-Cancer Therapy Pomalidomide Celgene Receives Positive CHMP Opinion as Treatment for Patients with Relapsed and Refractory Multiple Myeloma

May 30, 2013 07:50 PM Form 4 CELGENE CORP /DE/ For: May 29 Filed by: MARIO ERNEST

May 30, 2013 05:33 PM Form 4 CELGENE CORP /DE/ For: May 29 Filed by: HUGIN ROBERT J

May 30, 2013 05:32 PM Form 4 CELGENE CORP /DE/ For: May 28 Filed by: Daniel Thomas O

May 23, 2013 07:33 AM Celgene (CELG) Granted FDA Priority Review for ABRAXANE sNDA in Advanced Pancreatic Cancer

May 23, 2013 07:30 AM Celgene Announces U.S. FDA Grants Priority Review for ABRAXANE® sNDA in Advanced Pancreatic Cancer

May 14, 2013 05:49 PM Gene Therapy Company bluebird bio (BLUE) Files $86M IPO

May 10, 2013 08:15 AM Acceleron’s ACE-536 Preclinical Data Presentation Selected for Best Abstract at 12th International Symposium on Myelodysplastic Syndromes

May 9, 2013 04:06 PM NeoStem CEO's Letter to Shareholders

May 6, 2013 05:09 PM Form 8-K CELGENE CORP /DE/ For: May 06

Back to CELG Stock Lookup